BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8692535)

  • 1. p53 and MDM2 expression in oral squamous cell carcinoma.
    Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
    Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
    Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
    J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
    Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
    Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
    Zhang J; Liu H; Li S; Gu C
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
    Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
    Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
    Ng IO; Lam KY; Ng M; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of novel cell lines established from three human oral squamous cell carcinomas.
    Lee G; Kim YB; Kim JH; Kim MS; Shin KH; Won YS; Lee JI; Choung PH; Hyun BH; Min BM
    Int J Oncol; 2002 Jun; 20(6):1151-9. PubMed ID: 12011992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses?
    O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
    Diagn Mol Pathol; 2001 Sep; 10(3):190-9. PubMed ID: 11552722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
    Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
    Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into p53 protein stabilisation in oral squamous cell carcinoma.
    Partridge M; Kiguwa S; Emilion G; Pateromichelakis S; A'Hern R; Langdon JD
    Oral Oncol; 1999 Jan; 35(1):45-55. PubMed ID: 10211310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
    Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
    Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Waber PG; Chen J; Nisen PD
    Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective compartmentalization of different mdm2 proteins within the nucleus.
    Maxwell SA
    Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.